In vitro effects of mycophenolic acid on survival, function, and gene expression of pancreatic beta-cells

Acta Diabetologica

Volumn 49, Issue 1 SUPPL., 2012, Pages

  Gallo, R ^a,b   Natale, M ^a   Vendrame, F ^a,b   Boggi, U ^c   Filipponi, F ^c   Marchetti, P ^c   Laghi Pasini, F ^a   Dotta, F ^a,b  

^a UNIVERSITY OF SIENA   (Italy)

^b Fondazione Umberto Di Mario ONLUS   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Beta cells; Human islets; Immunosuppressive drugs; Mycophenolic acid; NODAT

Indexed keywords

GLUCOKINASE; GLUCOSE; INSULIN; MYCOPHENOLIC ACID; PROTEIN BAX; PROTEIN BCL 2; TRANSCRIPTION FACTOR PAX6; EYE PROTEIN; GLUCOSE TRANSPORTER 2; HOMEODOMAIN PROTEIN; IMMUNOSUPPRESSIVE AGENT; PAIRED BOX TRANSCRIPTION FACTOR; REPRESSOR PROTEIN;

ADULT; ANIMAL CELL; APOPTOSIS; ARTICLE; BAX GENE; BCL2 GENE; CELL FUNCTION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETOGENIC EFFECT; DOWN REGULATION; DRUG EFFECT; GENE; GENE EXPRESSION; GLUCOKINASE GENE; GLUT 2 GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN RELEASE; ISL1 GENE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PAX6 GENE; PRIORITY JOURNAL; ADOLESCENT; ANIMAL; CELL CULTURE; CELL LINE; CYTOLOGY; FEMALE; GENETICS; METABOLISM; MIDDLE AGED; PANCREAS ISLET; SECRETION (PROCESS);

ADOLESCENT; ADULT; ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; EYE PROTEINS; FEMALE; GENE EXPRESSION; GLUCOSE TRANSPORTER TYPE 2; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; MICE; MIDDLE AGED; MYCOPHENOLIC ACID; PAIRED BOX TRANSCRIPTION FACTORS; REPRESSOR PROTEINS; YOUNG ADULT;

EID: 84878895644     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-011-0368-8     Document Type: Article

References (44)

1. Allison AC, Eugui EM (2005) Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Transplantation 80(Suppl 2):S181-S190
2. Cohn RG, Mirkovich A, Dunlap B et al (1999) Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines. Transplantation 68(3):411-418
3. Kumar H, Mishra M, Bajpai S et al (2011) Correlation of insulin resistance, beta cell function and insulin sensitivity with serum sFas and sFasL in newly diagnosed type 2 diabetes. Acta Diabetol. doi: 10.1007/s00592-011- 0307-8
4. Wang AP, Li X, Zheng Y et al (2010) Thiazolidinediones protect mouse pancreatic β-cells directly from cytokine-induced cytotoxicity through PPARγ-dependent mechanisms. Acta Diabetol. doi: 10.1007/s00592-010-0239-8
5. Deng X, Cheng J, Zhang Y et al (2010) Effects of caloric restriction on SIRT1 expression and apoptosis of islet beta cells in type 2 diabetic rats. Acta Diabetol 47(Suppl 1):177-185
6. Montori VM, Basu A, Erwin PJ et al (2002) Post-transplantation diabetes: a systematic review of the literature. Diabetes Care 25(3):583-592. Review
7. American Diabetes Association Position Statement (2006) Standards of medical care in diabetes. Diabetes Care 29(Suppl 1):S4-S42
8. Bloom RD, Crutchlow MF (2008) Transplant-associated hyperglycemia. Transpl Rev (Orlando) 22(1):39-51. Review
9. Shapiro AMJ, Lakey JRT, Ryan EA et al (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive-regimen. N Engl J Med 343:230-238
10. Shapiro AM, Ricordi C, Hering BJ et al (2006) International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355(13):1318-1330
11. Drachenberg CB, Klassen DK, Weir MR et al (1999) Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 68(3):396-402
12. Fuhrer DK, Kobayashi M, Jiang H (2001) Insulin release and suppression by tacrolimus, rapamycin and cyclosporin A are through regulation of the ATP-sensitive potassium channel. Diabetes Obes Metab 3(6):393-402
13. Uchizono Y, Iwase M, Nakamura U et al (2004) Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulus-secretion coupling. Endocrinology 145(5):2264-2272
14. Efrat S, Linde S, Kofod H et al (1988) Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci USA 85(23):9037-9041
15. Lupi R, Dotta F, Marselli L et al (2002) Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets. Diabetes 51(5):1437-1442
16. Wang T, Brown MJ (1999) mRNA quantification by real time Taqman polymerase chain reaction: validation and comparison with Rnase protection. Anal Biochem 269(1):198-201
17. Marselli L, Dotta F, Piro S et al (2001) Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines. J Clin Endocrinol Metab 86(10):4974-4978
18. Poitout V, Stout LE, Armstrong MB et al (1995) Morphological and functional characterization of beta TC-6 cells: an insulin-secreting cell line derived from transgenic mice. Diabetes 44(3):306-313
19. Malyszko J, Malyszko JS, Mysliwiec M (2000) Effects of mycophenolate mofetil and mycophenolic acid on platelet aggregation in vitro. Transpl Proc 32(6):1347-1349
20. Gao R, Ustinov J, Korsgren O et al (2007) Effects of immunosuppressive drugs on in vitro neogenesis of human islets: mycophenolate mofetil inhibits the proliferation of ductal cells. Am J Transpl 7(4):1021-1026
21. Glomsda BA, Blaheta RA, Hailer NP (2003) Inhibition of monocyte/endothelial cell interactions and monocyte adhesion molecule expression by the immunosuppressant mycophenolate mofetil. Spinal Cord 41(11):610-619
22. Leckel K, Beecken WD, Jonas D et al (2003) The immunosuppressive drug mycophenolate mofetil impairs the adhesion capacity of gastrointestinal tumour cells. Clin Exp Immunol 134(2):238-245
23. Blaheta RA, Bogossian H, Beecken WD et al (2003) Mycophenolate mofetil increases adhesion capacity of tumor cells in vitro. Transplantation 76(12):1735-1741
24. Kamiyoshi Y, Takahashi M, Yokoseki O et al (2005) Mycophenolate mofetil prevents the development of experimental autoimmune myocarditis. J Mol Cell Cardiol 39(3):467-477
25. Li G, Segu VB, Rabaglia ME et al (1998) Prolonged depletion of guanosine triphosphate induces death of insulin-secreting cells by apoptosis. Endocrinology 139(9):3752-3762
26. Huo J, Luo RH, Metz SA et al (2002) Activation of caspase-2 mediates the apoptosis induced by GTP-depletion in insulin-secreting (HIT-T15) cells. Endocrinology 143(5):1695-1704
27. Park YJ, Ahn HJ, Chang HK et al (2009) The RhoGDI-alpha/JNK signaling pathway plays a significant role in mycophenolic acid-induced apoptosis in an insulin-secreting cell line. Cell Signal 21(2):356-364
28. Kim JY, Yoon SY, Park J et al (2006) Mycophenolic acid induces islet apoptosis by regulating mitogen-activated protein kinase activation. Transpl Proc 38(10):3277-3279
29. Matveyenko AV, Butler PC (2008) Relationship between beta-cell mass and diabetes onset. Diabetes Obes Metab 10(Suppl 4):23-31
30. North KE, Franceschini N, Avery CL et al (2010) Variation in the checkpoint kinase 2 gene is associated with type 2 diabetes in multiple populations. Acta Diabetol 47(Suppl 1):199-207
31. Yuan L, Li X, Li J et al (2010) Effects of renin-angiotensin system blockade on the islet morphology and function in rats with long-term high-fat diet. Acta Diabetol. doi: 10.1007/s00592-010-0210-8
32. Paty BW, Harmon JS, Marsh CL et al (2002) Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation 73(3):353-357
33. Hui H, Khoury N, Zhao X et al (2005) Adenovirus-mediated XIAP gene transfer reverses the negative effects of immunosuppressive drugs on insulin secretion and cell viability of isolated human islets. Diabetes 54(2):424-433
34. Johnson JD, Ao Z, Ao P et al (2009) Different of FK506, rapamycin and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. Cell Transpl 18:833-845
35. Meredith M, Li G, Metz SA (1997) Inhibition of calcium-induced insulin secretion from intact HIT-T15 or INS-1 beta cells by GTP depletion. Biochem Pharmacol 53(12):1873-1882
36. German MS (1993) Glucose sensing in pancreatic islet beta cells: the key role of glucokinase and the glycolytic intermediates. Proc Natl Acad Sci USA 90(5):1781-1785
37. Matschinsky F, Liang Y, Kesavan P et al (1993) Glucokinase as pancreatic beta cell glucose sensor and diabetes gene. J Clin Invest 92(5):2092-2098. Review
38. Sander M, Neubuser A, Kalamaras J et al (1997) Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev 11:1662-1673
39. Hamasaki A, Yamada Y, Kurose T et al (2007) Adult pancreatic islets require differential pax6 gene dosage. Biochem Biophys Res Commun 353(1):40-46
40. Wen JH, Chen YY, Song SJ et al (2009) Paired box 6 (PAX6) regulates glucose metabolism via proinsulin processing mediated by prohormone convertase 1/3 (PC1/3). Diabetologia 52:504-513
41. Yasuda T, Kajimoto Y, Fujitani Y et al (2002) PAX6 mutation as a genetic factor common to aniridia and glucose intolerance. Diabetes 51(1):224-230
42. Ashery-Padan R, Zhou X, Marquardt T et al (2004) Conditional inactivation of Pax6 in the pancreas causes early onset of diabetes. Dev Biol 269(2):479-488
43. Karlsson O, Thor S, Norberg T et al (1990) Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo- and a cys-his domain. Nature 344(6269):879-882
44. Ahlgren U, Pfaff SL, Jessell TM et al (1997) Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature 385(6613):257-260